4 most recent filings and news items mentioning COCP. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/COCP/news?limit=20"
Pull COCP filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayCocrystal Pharma entered into a securities purchase agreement with OPKO Health, Inc. for the sale of common stock. The terms set a floor for the share price based on the Nasdaq Consolidated Bid Price.
View filing at SEC.gov →Cocrystal Pharma announced the appointment of James Sapirstein as Chief Executive Officer effective June 3, 2026, with a $265,000 annual salary and 235,000 stock options. The leadership change signals organizational transition and provides equity incentive alignment with company
View filing at SEC.gov →Cocrystal Pharma appointed James Sapirstein as Chief Executive Officer effective immediately, replacing co-CEOs Sam Lee and Jim Martin. Sapirstein brings 23 product launches and extensive antiviral development experience from prior roles at Contravir, Tobira, and Gilead Sciences.
View filing at SEC.gov →Cocrystal Pharma announced discovery of novel direct-acting antivirals with pan-viral activity against hantavirus, bunyavirus and influenza, targeting a conserved viral replication enzyme region. The announcement addresses significant unmet medical needs for hantavirus and bunyav
View filing at SEC.gov →